Div Gupta

Partner

+1 212 479 6474
dgupta@cooley.com

Div Gupta's practice focuses on the representation of public and private emerging growth companies and investment banking firms. He has handled a variety of significant business transactions, including public offerings of equity, high yield debt and convertible debt, venture capital financings and mergers and acquisitions. He also advises a number of private companies as well as public companies on securities and general corporate matters. Div is ranked in Legal 500 and Chambers USA for his work in Capital Markets and Healthcare: Life Sciences and has been named by Law360 as a Rising Star in Capital Markets and recognized by Who's Who Legal as a leading life sciences lawyer. Div is consistently among the nation's leaders in IPOs and other capital markets transactions run year after year.

Download full bio

Experience

  • Opthea – $128 Million IPO 

  • Dyne Therapeutics – $268 Million IPO 

  • ADC Therapeutics – $233 Million IPO 

  • iTeos Therapeutics – $201 Million IPO 

  • Inventiva – $108 Million IPO 

  • View all

Education

  • Harvard Law School
    JD, cum laude, 2000

  • Yale University
    BS, magna cum laude, Phi Beta Kappa, 1997


Admissions & Credentials

California

New York

Texas

Rankings & Accolades

    Chambers USA: Capital Markets - Nationwide (Eastern United States) (2020)

    Legal 500: Key Lawyer - Capital Markets: Equity Offerings and Healthcare: Life Sciences (2020)

    Law 360 Rising Star (2015)

    Who's Who Legal: Life Sciences (2018)

Contact

+1 212 479 6474 office
dgupta@cooley.com

55 Hudson Yards
New York, NY 10001-2157